Company intelligence / Profile preview

SlavaMed

Belgrade, Serbia

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Slaviamed is a Serbian pharmaceutical company dedicated to the development, manufacturing, and distribution of high-quality generic pharmaceutical products. Headquartered in Belgrade, the company operates advanced manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards. Slaviamed's extensive product portfolio covers critical therapeutic areas, including cardiovascular health, central nervous system disorders, and anti-inflammatory treatments. As a significant player in the Balkan pharmaceutical market, the company focuses on providing affordable and effective medications to meet regional healthcare needs.

Therapeutic areas: ImmunologyCardiovascularNeurologyInfectious DiseasesPsychiatry
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on SlavaMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SlavaMed.

Explore the full profile